alexa Nanoparticles Open Access Journals|OMICS International|Translational Medicine

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Nanoparticles Open Access Journals

As part to boost knowledge-sharing through real-time interaction, this open access group has been organizing over 100 world-class scientific conferences at global venues through the calendar year. A collaboration set up recently with 100 international societies would provide a window to wider knowledge-base of worldwide open access health-related information. Abstracts presented at the meets are invited from scholars with a track record of effective research papers that are also published as special journal issue for each of the conference.About 700+ peer-reviewed journals are handled by more than 25000 editorial board members who belong to both academic and industrial circles in all aspects of Science, Engineering, Management and Technology journals. The use of nanoparticles for drug delivery is likely one of the most clinically important applications of cancer nanotechnology.Encapsulation of hydrophobic drugs into nanoparticles can render the drug completely dispersible in water, making the drug intravenously injectable. After the drug loaded nanoparticles are administrated, the drug can be released from nanoparticles to play its role.PH-sensitive nanoparticles can be used to slowly release drugs at physiological condition (pH=7.4), but fast release at acid condition (pH=5~5.5), leading to the selective release of anticancer drug in tumor site.Nanoparticles can reduce extravasation of drug from the normal blood vessel but not angiogenic blood vessels in tumor, contributing to reduce the side effects.Recent studies indicated that encapsulation of doxorubicin in nanoparticles can provide a platform technology for improving the anticancer efficiency as well as reducing the side effects and liposomal doxorubicin is already marketed for cancer treatment. (Maling Gou,Promising Application of Nanotechnology in Anticancer Drug Delivery)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014